Literature DB >> 2913040

Isolation of human immunodeficiency virus from peripheral blood lymphocytes stored in various transport media and frozen at -60 degrees C.

D Gallo1, J S Kimpton, P J Johnson.   

Abstract

The peripheral blood lymphocytes from 48 heparinized blood specimens from human immunodeficiency virus (HIV) antibody-positive individuals were divided into two aliquots. One aliquot was reconstituted in one of the following five media. Medium 1 consisted of tryptose broth with 0.5% gelatin; medium 2 consisted of RPMI 1640 containing 10% fetal bovine serum (FBS); medium 3 consisted of RPMI 1640 containing 20% FBS, Polybrene, interleukin 2, and anti-alpha interferon; medium 4 consisted of medium 2 plus 10% dimethyl sulfoxide (DMSO); and medium 5 consisted of medium 3 plus 10% DMSO. Lymphocytes were stored in these five media at -60 degrees C. The other aliquot of cells was stored at -190 degrees C in RPMI 1640 containing 50% FBS and 10% DMSO. After 1 week, both aliquots were cocultivated with phytohemagglutinin-stimulated uninfected peripheral blood lymphocytes, and presence of HIV was detected by the reverse transcriptase test. Storage in medium 1, 2, or 3 did not result in satisfactory isolation rates, but storage at -60 degrees C in medium 4 or 5 gave equal or better isolation rates than did storage at -190 degrees C. Inactivation of HIV by freezing of the cells without DMSO correlated with high antibody titers to core and polymerase proteins as measured by Western (immuno-) blotting.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2913040      PMCID: PMC267238          DOI: 10.1128/jcm.27.1.88-90.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  4 in total

1.  Comparative studies on use of fresh and frozen peripheral blood lymphocyte specimens for isolation of human immunodeficiency virus and effects of cell lysis on isolation efficiency.

Authors:  D Gallo; J S Kimpton; P J Dailey
Journal:  J Clin Microbiol       Date:  1987-07       Impact factor: 5.948

2.  Antibody that inhibits human immunodeficiency virus reverse transcriptase and association with inability to isolate virus.

Authors:  K Sano; M H Lee; F Morales; P Nishanian; J Fahey; R Detels; D T Imagawa
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

3.  Prospect for prevention of human immunodeficiency virus infection: purified 120-kDa envelope glycoprotein induces neutralizing antibody.

Authors:  W G Robey; L O Arthur; T J Matthews; A Langlois; T D Copeland; N W Lerche; S Oroszlan; D P Bolognesi; R V Gilden; P J Fischinger
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

4.  Comparison of detection of antibody to the acquired immune deficiency syndrome virus by enzyme immunoassay, immunofluorescence, and Western blot methods.

Authors:  D Gallo; J L Diggs; G R Shell; P J Dailey; M N Hoffman; J L Riggs
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

  4 in total
  3 in total

Review 1.  Transport of viral specimens.

Authors:  F B Johnson
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

2.  HIV Apheresis Tags (HIVAT) Aided Elimination of Viremia.

Authors:  Marek Malecki; Bianka Saetre
Journal:  Mol Cell Ther       Date:  2018-06-21

Review 3.  The diagnosis of human immunodeficiency virus infection: progress in less than five years.

Authors:  F J Michalski
Journal:  Yale J Biol Med       Date:  1989 Mar-Apr
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.